{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:55:58Z","timestamp":1793094958852,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Invasive fungal infections are a serious complication for haematology patients. However, there is no study on this subject in Reunion Island. The aim of this study was to estimate the incidence of invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island. We conducted a descriptive and ambispective study. We included any patient with haematological malignancy presenting with a putative, possible, probable, or proven invasive fungal infection, defined as per the criteria of the European Organisation for Research and Treatment of Cancer\/Mycoses Study Group 2019, from January 2018 to December 2022. Data were collected from medical records and identified by ICD-10 coding and laboratory data. Eighty-nine invasive fungal infections were diagnosed in 76 patients. The 5-year incidence rate of invasive fungal infections was 1.7 per 100 person-years (95% Confidence Interval (CI) 1.3\u20132). Invasive aspergillosis was the most common infection (35\/89, 39%), followed by invasive candidiasis (33\/89, 37%), mucormycosis (7\/89, 8%), and pneumocystosis (7\/89, 8%). Most infections occurred in patients with acute myeloid leukaemia (32\/89, 36%) and lymphoma (26\/89, 29%). Six-month mortality was higher for mucormycosis (71%) than for aspergillosis (34%) and invasive candidiasis (33%). The incidence and distribution of fungal infections in haematology patients were similar to European cohorts, albeit with more mucormycosis, less pneumocystis, and a high proportion of Candida parapsilosis in candidemia.<\/jats:p>","DOI":"10.1093\/mmy\/myae102","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:23:02Z","timestamp":1729038182000},"source":"Crossref","is-referenced-by-count":5,"title":["Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018\u20132022): An observational study"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8539-164X","authenticated-orcid":false,"given":"Camille","family":"Estagnasi\u00e9","sequence":"first","affiliation":[{"name":"Infectious Diseases, CHU La R\u00e9union , Saint-Denis ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mohr","sequence":"additional","affiliation":[{"name":"Hematology Department, CHU La R\u00e9union , Saint-Pierre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Kamus","sequence":"additional","affiliation":[{"name":"Mycology Department, CHU La R\u00e9union , Saint-Denis ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Zunic","sequence":"additional","affiliation":[{"name":"Hematology Department, CHU La R\u00e9union , Saint-Pierre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Chirpaz","sequence":"additional","affiliation":[{"name":"Public Health Division, CHU La R\u00e9union , Saint-Denis ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Moiton","sequence":"additional","affiliation":[{"name":"Infectious Diseases, CHU La R\u00e9union , Saint-Denis ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lagrange-Xelot","sequence":"additional","affiliation":[{"name":"Infectious Diseases, CHU La R\u00e9union , Saint-Denis ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"2024102613115146200_bib1","first-page":"109","article-title":"Mycoses invasives en France m\u00e9tropolitaine, PMSI 2001\u20132010?: incidence, l\u00e9talit\u00e9 et tendances","volume":"12\u201313","author":"Bitar","year":"2013","journal-title":"Bull Epid\u00e9miol Hebdomad"},{"issue":"6","key":"2024102613115146200_bib2","doi-asserted-by":"crossref","first-page":"FSO307","DOI":"10.4155\/fsoa-2018-0019","article-title":"Invasive fungal infections in high-risk patients: report from TIMM-8 2017","volume":"4","author":"Pagano","year":"2018","journal-title":"Future Sci OA"},{"issue":"8","key":"2024102613115146200_bib3","first-page":"1068\u221275","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"2024102613115146200_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2024102613115146200_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.idc.2019.02.006","article-title":"Fungal infections of the stem cell transplant recipient and hematologic malignancy patients","volume":"33","author":"Bays","year":"2019","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"2024102613115146200_bib6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/myc.13148","article-title":"Breakthrough invasive fungal infections: who is at risk?","volume":"63","author":"Jenks","year":"2020","journal-title":"Mycoses"},{"issue":"6","key":"2024102613115146200_bib7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"3","key":"2024102613115146200_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/myc.13205","article-title":"Epidemiology of invasive fungal disease in haematologic patients","volume":"64","author":"Souza","year":"2021","journal-title":"Mycoses."},{"issue":"8","key":"2024102613115146200_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/jof7080588","article-title":"Epidemiology of invasive fungal diseases in patients with hematologic malignancies and hematopoietic cell transplantation recipients managed with an antifungal diagnostic driven approach","volume":"7","author":"Bergamasco","year":"2021","journal-title":"J Fungi."},{"issue":"1","key":"2024102613115146200_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1590\/0037-8682-0191-2016","article-title":"Invasive fungal infection in patients with hematologic disorders in a Brazilian tertiary care hospital","volume":"50","author":"Junior","year":"2017","journal-title":"Rev Soc Bras Med Trop"},{"issue":"6","key":"2024102613115146200_bib11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12185-012-1210-y","article-title":"Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies","volume":"96","author":"Kurosawa","year":"2012","journal-title":"Int J Hematol"},{"key":"2024102613115146200_bib12","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2147\/IDR.S405810","article-title":"Epidemiology and factors associated with treatment success of invasive fungal infections among newly hematologic malignancy patients receiving chemotherapy or hematopoietic stem cell transplant in Thailand","volume":"16","author":"Weeraphon","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"1","key":"2024102613115146200_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1756-0500-4-42","article-title":"Prevalence of invasive fungal disease in hematological patients at a tertiary university hospital in Singapore","volume":"4","author":"Lee","year":"2011","journal-title":"BMC Res Notes"},{"issue":"12","key":"2024102613115146200_bib14","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"2024102613115146200_bib15","doi-asserted-by":"crossref","first-page":"e00920","DOI":"10.1128\/mbio.00920-22","article-title":"Active surveillance program to increase awareness on invasive fungal diseases: the French RESSIF Network (2012 to 2018)","volume":"13","author":"Bretagne","year":"2022","journal-title":"mBio"},{"issue":"5","key":"2024102613115146200_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/ciab1066","article-title":"Evaluation of serum mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial","volume":"75","author":"Millon","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2024102613115146200_bib17","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"2024102613115146200_bib18","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1128\/JCM.00962-16","article-title":"Identification by molecular methods and matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry and antifungal susceptibility profiles of clinically significant rare Aspergillus species in a Referral Chest hospital in Delhi, India","volume":"54","author":"Masih","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2024102613115146200_bib19","doi-asserted-by":"crossref","first-page":"101328","DOI":"10.1016\/j.mycmed.2022.101328","article-title":"A systematic review of epidemiology, risk factors, diagnosis, antifungal resistance, and management of invasive aspergillosis in Africa","volume":"33","author":"Yerbanga","year":"2023","journal-title":"J Med Mycol"},{"issue":"12","key":"2024102613115146200_bib20","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"2024102613115146200_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jinf.2018.02.012","article-title":"The burden of invasive aspergillosis in patients with haematological malignancy: a meta-analysis and systematic review","volume":"76","author":"van\u00a0de\u00a0Peppel","year":"2018","journal-title":"J Infect."},{"issue":"9","key":"2024102613115146200_bib22","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing incidence of zygomycosis (Mucormycosis), France,\u00a01997\u20132006","volume":"15","author":"Bitar","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"2024102613115146200_bib23","doi-asserted-by":"crossref","first-page":"e13083","DOI":"10.1111\/eci.13083","article-title":"Fungaemia in haematological malignancies: SEIFEM-2015 survey","volume":"49","author":"Criscuolo","year":"2019","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"2024102613115146200_bib24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/cid\/civ293","article-title":"Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)","volume":"61","author":"Cornely","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2024102613115146200_bib25","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/myc.13130","article-title":"Candidaemia in haematological malignancy patients from a SEIFEM study: epidemiological patterns according to antifungal prophylaxis","volume":"63","author":"Posteraro","year":"2020","journal-title":"Mycoses"},{"issue":"4","key":"2024102613115146200_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","article-title":"Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance\u00ae) registry, 2004\u20132008","volume":"74","author":"Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"2024102613115146200_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"25","key":"2024102613115146200_bib28","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1056\/NEJMe020142","article-title":"Echinocandins\u2014an advance in the primary treatment of invasive candidiasis","volume":"347","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"2024102613115146200_bib29","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2147\/IDR.S402754","article-title":"Candida haemulonii complex and Candida auris: biology, virulence factors, immune response, and multidrug resistance","volume":"16","author":"G\u00f3mez-Gaviria","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"10","key":"2024102613115146200_bib30","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/cid\/ciad064","article-title":"Prevalence of ocular candidiasis and Candida endophthalmitis in patients with candidemia: a systematic review and meta-analysis","volume":"76","author":"Phongkhun","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2024102613115146200_bib31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/mmy\/myz104","article-title":"Risk factors predicting Candida infective endocarditis in patients with candidemia","volume":"58","author":"Foong","year":"2020","journal-title":"Med Mycol"},{"issue":"5","key":"2024102613115146200_bib32","doi-asserted-by":"crossref","first-page":"e0127534","DOI":"10.1371\/journal.pone.0127534","article-title":"Clinical and therapeutic aspects of candidemia: a five year single centre study","volume":"10","author":"Bassetti","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"2024102613115146200_bib33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","article-title":"The risk and clinical outcome of candidemia depending on underlying malignancy","volume":"43","author":"The French Mycoses Study Group","year":"2017","journal-title":"Intensive Care Med"},{"issue":"5","key":"2024102613115146200_bib34","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1128\/JCM.44.5.1681-1685.2006","article-title":"Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003","volume":"44","author":"Almirante","year":"2006","journal-title":"J Clin Microbiol."}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myae102\/59766143\/myae102.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/10\/myae102\/60122620\/myae102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/10\/myae102\/60122620\/myae102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T13:12:06Z","timestamp":1729948326000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myae102\/7823294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,4]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myae102","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,10]]},"article-number":"myae102"}}